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http://dx.doi.org/10.1016/j.ajpath.2012.04.002This Month in AJPImproving Prediction of Relapse in Prostate
Cancer
Predicting the clinical outcome of prostate cancer remains a
major challenge, even with prostate-specific antigen (PSA)
monitoring. Using specific copy number variation (CNV)
patterns in tumor or benign prostate tissues adjacent to
cancer samples, Yu et al (Am J Pathol 2012, 180:2240–
2248) generated prediction models of prostate cancer re-
lapse or short PSA doubling time (PSADT). In addition,
mean and median sizes of CNV from patients’ blood, be-
nign prostate tissues adjacent to the tumor, and tumor
samples were also predictive of these clinical outcomes,
independent of specific genes and regions. By using me-
dian-sized CNV from blood and tumor, the genome model
correctly predicted cases for both relapse and short
PSADT. Thus, CNV genome analysis of blood, normal pros-
tate, or tumor tissues of prostate cancer patients holds
promise for more efficiently and accurately predicting the
behavior of prostate cancer.
New Roles for p53 in Mitochondrial
Homeostasis and Antiretroviral Toxicity
The direct roles of p53 in mitochondrial DNA (mtDNA) rep-
lication and function are not well understood. Koczor et al
(Am J Pathol 2012, 180:2276–2283) used a mitochondrial-
targeted p53 (MTS-p53) to tease out p53’s effects. MTS-
p53 decreased cellular proliferation and mtDNA abun-
dance in HepG2 cells transfected with wild-type human
p53. Treatment of MTS-p53 cells with nucleoside reverse
transcriptase inhibitor (NRTI) led to mtDNA depletion. A
truncated p53 (MTS-p53-290) that localizes exclusively to
the mitochondria caused cells to proliferate at control levels
but yielded decreased mtDNA abundance and mitochon-
drial function following NRTI treatment. Further, the MTS-
p53-290 cells demonstrated that only the nuclear fraction of
p53 controlled cellular proliferation. This work demonstrates
that overexpression of p53 negatively affects the normal
mitochondrial homeostasis in the cells, thus providing new
insights into p53’s roles in the cell.
NS1 Single Point Mutation (Y89F) Limits
Influenza A Virus Virulence
The nonstructural protein 1 (A/NS1) of influenza A viruses
(IAVs) harbors several Src homology (SH)-bindingmotifs (bm)
that mediate interactions with cellular proteins. The highly con-
served Y89 of SH2bm prompted Hrincius et al (Am J Pathol
2012, 180:2361–2374) to evaluate its necessity for IAV viru-
lence. The highly conserved SH2bm was crucial for efficientreplication of IAV in vitro and in vivo. Furthermore, in an in vivo
mouse model, disruption of this motif (Y89F) restricted virus
distribution in the entire mouse lung, limited replication almost
entirely to the alveoli, reduced the inflammatory response and
pathological changes in the lung, and resulted in dramatically
reduced virulence. These findings demonstrate that the
change of a single residue of the highly conserved SH2bm
within the A/NS1 restricts virus spread and strongly reduces
virulence, further fostering A/NS1 as suitable target for antiviral
interventions.
CTGF Causes Glaucoma by Modifying the
Trabecular Meshwork
The most critical risk factor for optic nerve damage in pri-
mary open-angle glaucoma (POAG) is increased intraocu-
lar pressure (IOP) caused by a resistance to aqueous hu-
mor outflow in the trabecular meshwork (TM). The TGF-2
target gene connective tissue growth factor (CTGF) is highly
expressed in the TM. Junglas et al (Am J Pathol 2012,
180:2386–2403) demonstrate that increased expression of
CTGF in mice causes phenotypes similar to that observed
in patients with POAG: open iridocorneal angle, high IOP,
and degeneration of optic nerve axons. The mechanism for
increased IOP in mice appears to involve direct action of
CTGF on the TM actin cytoskeleton, a scenario that might
be similarly involved in the pathogenesis of POAG. The
CTGF-overexpressing mice therefore provide a model that
mimics human POAG and offers a molecular mechanism to
explain the increase of its most critical risk factor.
MacroH2A1.1 Expression Can Predict
Outcome in Colon Cancer
Histone variant macroH2A1 has two splice isoforms,
macroH2A1.1 and macroH2A1.2, that possess tissue- and
cell-specific expression patterns, with studies in breast and
lung cancer demonstrating a strong correlation between
macroH2A1.1 levels and proliferation. Sporn and Jung
(Am J Pathol 2012, 180:2516–2526) assessed the differen-
tial regulation and predictive potential of macroH2A1 iso-
forms in colon cancer. MacroH2A1.1 mRNA was down-
regulated in primary colorectal cancer samples compared
to matched normal colon tissue, whereas macroH2A1.2
was up-regulated. At the protein level, macroH2A1.1 down-
regulation correlated significantly with patient outcome, and
loss with a worse outcome. Loss of macroH2A1.1 in vitro
was associated with cell growth andmetastasis. These data
demonstrate the differential regulation of macroH2A1 iso-
forms in colon cancer, thus identifying macroH2A1.1 as a
novel colon cancer biomarker.
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